Application 010418
- Type
- NDA
- Sponsor
- ASTRAZENECA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 005 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1% | No | No |
| 006 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1% | No | No |
| 007 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2% | No | No |
| 008 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;2% | No | No |
| 009 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1.5% | No | No |
| 010 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1.5% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010418-005 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-006 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-007 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 2% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-008 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-009 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010418-010 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-009 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010418-010 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-005 | XYLOCAINE | 1% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-006 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-007 | XYLOCAINE | 2% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010418-008 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | 4dd52202-8eef-4136-92dd-ada573b7cf74 | 2025-04-22 | Warnings, Adverse reactions | Xylocaine LIDOCAINE HYDROCHLORIDE |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Xttrium Laboratories, Inc. | 31a5a48e-27d7-90f3-e063-6294a90a2d9e | 2025-03-31 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | cddb2b22-fce3-8967-6e54-dca3df5ac4b3 | 2025-03-26 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | abf60c5c-66df-4894-aa8f-bf770a6e9d00 | 2025-03-24 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 037764d3-da0e-5ebb-e063-6294a90ab6e0 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| XeroBurn Burn Gel | LIDOCAINE HYDROCHLORIDE | Dynarex Corporation | 58985046-ca9c-12be-e053-2991aa0abe72 | 2025-03-13 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Novagenix Labs LLC | 7567ffb5-953a-4be9-9a02-c5a50dcd9306 | 2025-03-12 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | ARMAS PHARMACEUTICALS INC. | 2f6e0f3d-ceaf-a853-e063-6394a90a8efb | 2025-03-07 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lightning Products BURN RELIEF | LIDOCAINE HYDROCHLORIDE | Nantong Health & Beyond Hygienic Products Inc. | 555ac696-e761-4a5a-bed8-945dc64d5be5 | 2025-02-27 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | f1b26274-a55e-4321-b96c-ce0df830f205 | 2025-02-20 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | McKesson Corporation dba SKY Packaging | e1eabd6b-9bb8-646f-e053-2a95a90a7b83 | 2025-02-20 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | NorthStar RxLLC | 6a7fa6c5-b550-46ac-99a3-5c49339e6dbd | 2025-02-19 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Eugia US LLC | 9916b09d-a116-469d-92d5-60e50ea9782b | 2025-02-07 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| TheraCare Pain Relieving Lidocaine Cream | LIDOCAINE HYDROCHLORIDE | Veridian Healthcare | 2d42192b-8889-a896-e063-6294a90a4fc8 | 2025-02-03 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Eugia US LLC | ccc38d8a-43fd-44c0-985e-32af9ed956ab | 2025-02-03 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | d5e23ede-957c-4a32-b1c6-268acb773c31 | 2025-01-31 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE |
| INTIMALE LIDOCAINE DELAY | LIDOCAINE HYDROCHLORIDE | SKINS SEXUAL HEALTH LIMITED | 5ddd7d56-bf51-462b-afcd-944861e49781 | 2025-01-28 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Meijer Odor Free Analgesic Pain Relieving Topical Analgesic | LIDOCAINE HYDROCHLORIDE | Meijer Distribution, Inc | 6288efea-f636-4eea-bb9f-78aa2f9af54a | 2025-01-14 | Warnings | LIDOCAINE HYDROCHLORIDE |
| IKONIK TONIK | LIDOCAINE HYDROCHLORIDE | IKONIK CARE, LLC | 122fdfe8-b5fa-46d1-9fd9-3df9887ed320 | 2025-01-14 | Warnings | LIDOCAINE HYDROCHLORIDE |
| Burn Jel | LIDOCAINE HYDROCHLORIDE | Water-Jel Technologies | ff621b46-2342-41db-994d-851a09796d08 | 2025-01-06 | Warnings | LIDOCAINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.